Identification of TP53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies

por Calapre, Leslie, Giardina, Tindaro, Beasley, Aaron B., Reid, Anna L., Stewart, Colin, Amanuel, Benhur, Meniawy, Tarek M., Gray, Elin S.
Publicado 2023

Supervised resistance exercise for women with ovarian cancer who have completed first-line treatment: a pragmatic study

por Schofield, Christelle, Newton, Robert U., Taaffe, Dennis R., Galvão, Daniel A., Cohen, Paul A., Meniawy, Tarek M., Peddle-McIntyre, Carolyn J.
Publicado 2023

Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients

por Asante, Du-Bois, Mohan, Ganendra R. K. A., Acheampong, Emmanuel, Ziman, Melanie, Calapre, Leslie, Meniawy, Tarek M., Gray, Elin S., Beasley, Aaron B.
Publicado 2023

Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors

por Dart, Sarah J., Cook, Alistair M., Millward, Michael J., McDonnell, Alison M., Chin, Wee L., Hakeem, Muhammad U., Meniawy, Tarek M., Bowyer, Samantha E.
Publicado 2021

Associations of Physical Activity and Exercise with Health-related Outcomes in Patients with Melanoma During and After Treatment: A Systematic Review

por Crosby, Brendan J., Lopez, Pedro, Galvão, Daniel A., Newton, Robert U., Taaffe, Dennis R., Meniawy, Tarek M., Warburton, Lydia, Khattak, Muhammad A., Gray, Elin S., Singh, Favil
Publicado 2021

Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy

por Crosby, Brendan J., Newton, Robert U., Galvão, Daniel A., Taaffe, Dennis R., Lopez, Pedro, Meniawy, Tarek M., Khattak, Muhammad A., Lam, Wei‐Sen, Gray, Elin S., Singh, Favil
Publicado 2023

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

por McEvoy, Ashleigh C., Warburton, Lydia, Al-Ogaili, Zeyad, Celliers, Liesl, Calapre, Leslie, Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Publicado 2018

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies

por McEvoy, Ashleigh C., Pereira, Michelle R., Reid, Anna, Pearce, Robert, Cowell, Lester, Al-Ogaili, Zeyad, Khattak, Muhammad A., Millward, Michael, Meniawy, Tarek M., Gray, Elin S., Ziman, Melanie
Publicado 2019

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device

por Aya-Bonilla, Carlos A., Marsavela, Gabriela, Freeman, James B., Lomma, Chris, Frank, Markus H., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Warkiani, Majid E., Gray, Elin S., Ziman, Mel
Publicado 2017

Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma

por McEvoy, Ashleigh C., Calapre, Leslie, Pereira, Michelle R., Giardina, Tindaro, Robinson, Cleo, Khattak, Muhammad A., Meniawy, Tarek M., Pritchard, Antonia L., Hayward, Nicholas K., Amanuel, Benhur, Millward, Michael, Ziman, Melanie, Gray, Elin S.
Publicado 2017

Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients

por Asante, Du-Bois, Morici, Michael, Mohan, Ganendra R. K. A., Acheampong, Emmanuel, Spencer, Isaac, Lin, Weitao, van Miert, Paula, Gibson, Samantha, Beasley, Aaron B., Ziman, Melanie, Calapre, Leslie, Meniawy, Tarek M., Gray, Elin S.
Publicado 2021

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

por Creaney, Jenette, Dick, Ian M, Meniawy, Tarek M, Leong, Su Lyn, Leon, Justine S, Demelker, Yvonne, Segal, Amanda, (Bill) Musk, A W, Lee, Y C Gary, Skates, Steven J, Nowak, Anna K, Robinson, Bruce W S
Publicado 2014

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression

por Marsavela, Gabriela, McEvoy, Ashleigh C., Pereira, Michelle R., Reid, Anna L., Al-Ogaili, Zeyad, Warburton, Lydia, Khattak, Muhammad A., Abed, Afaf, Meniawy, Tarek M., Millward, Michael, Ziman, Melanie R., Calapre, Leslie, Gray, Elin S.
Publicado 2021

Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma

por Calapre, Leslie, Giardina, Tindaro, Robinson, Cleo, Reid, Anna L., Al‐Ogaili, Zeyad, Pereira, Michelle R., McEvoy, Ashleigh C., Warburton, Lydia, Hayward, Nicholas K., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Amanuel, Benhur, Ziman, Melanie, Gray, Elin S.
Publicado 2018

The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies—Beyond BRAF Mutant Detection

por Marsavela, Gabriela, Johansson, Peter A., Pereira, Michelle R., McEvoy, Ashleigh C., Reid, Anna L., Robinson, Cleo, Warburton, Lydia, Khattak, Muhammad A., Meniawy, Tarek M., Amanuel, Benhur, Millward, Michael, Hayward, Nicholas K., Ziman, Melanie R., Gray, Elin S., Calapre, Leslie
Publicado 2020

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study

por O'Malley, David M., Neffa, Maryna, Monk, Bradley J., Melkadze, Tamar, Huang, Marilyn, Kryzhanivska, Anna, Bulat, Iurie, Meniawy, Tarek M., Bagameri, Andrea, Wang, Edward W., Doger de Speville Uribe, Bernard, Hegg, Roberto, Ortuzar Feliu, Waldo, Ancukiewicz, Marek, Lugowska, Iwona
Publicado 2022

Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies

por Clark, Michael E., Rizos, Helen, Pereira, Michelle R., McEvoy, Ashleigh C., Marsavela, Gabriela, Calapre, Leslie, Meehan, Katie, Ruhen, Olivia, Khattak, Muhammad A., Meniawy, Tarek M., Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Publicado 2020

Detection of metastases using circulating tumour DNA in uveal melanoma

por Beasley, Aaron B., de Bruyn, Daniël P., Calapre, Leslie, Al-Ogaili, Zeyad, Isaacs, Timothy W., Bentel, Jacqueline, Reid, Anna L., Dwarkasing, Roy S., Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Brosens, Erwin, de Klein, Annelies, Chen, Fred K., Kiliҫ, Emine, Gray, Elin S.
Publicado 2023

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

por Gray, Elin S., Rizos, Helen, Reid, Anna L., Boyd, Suzanah C., Pereira, Michelle R., Lo, Johnny, Tembe, Varsha, Freeman, James, Lee, Jenny H.J., Scolyer, Richard A., Siew, Kelvin, Lomma, Chris, Cooper, Adam, Khattak, Muhammad A., Meniawy, Tarek M., Long, Georgina V., Carlino, Matteo S., Millward, Michael, Ziman, Melanie
Publicado 2015

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

por Kirkwood, John M., Del Vecchio, Michele, Weber, Jeffrey, Hoeller, Christoph, Grob, Jean-Jacques, Mohr, Peter, Loquai, Carmen, Dutriaux, Caroline, Chiarion-Sileni, Vanna, Mackiewicz, Jacek, Rutkowski, Piotr, Arenberger, Petr, Quereux, Gaelle, Meniawy, Tarek M., Ascierto, Paolo A., Menzies, Alexander M., Durani, Piyush, Lobo, Maurice, Campigotto, Federico, Gastman, Brian, Long, Georgina V.
Publicado 2023